Role of Inflammation and Epigenetics in Benign Prostate Pathology

炎症和表观遗传学在良性前列腺病理学中的作用

基本信息

批准号：
8443689
负责人：
CHARLES J. BIEBERICH
金额：
$ 7.25万
依托单位：
UNIVERSITY OF MARYLAND BALTIMORE COUNTY
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-09-30 至 2013-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8443689
关键词：
Accounting Affect Architecture Benign Benign Prostatic Hypertrophy Biological Models Biology Cells Clinical Clinical Research Complex DNA Methylation Data Development Differentiation and Growth Disease Drug Delivery Systems Epigenetic Process Epithelial Epithelial Cells Epithelium Etiology Event Foundations Future Gene Expression Gene Expression Profile Genetic Goals Growth Disorders Health Human Individual Inflammation Inflammatory Inflammatory Response Lesion Life Long-Term Effects Mediating Mediator of activation protein Molecular Molecular Profiling Morbidity - disease rate Morphology Non-Malignant Office Visits Outcome Outpatients Pathologist Pathology Pathway interactions Patients Pattern Pelvic Pain Pharmaceutical Preparations Prostate Prostatectomy Prostatic Diseases Quality of life Radical Prostatectomy Research Role Sampling Signal Transduction Solid Stromal Cells Symptoms Syndrome Testing Therapeutic Tissues Transgenic Mice Translating Urinary tract Validation Work base cytokine epigenomics experience genome-wide insight intestinal epithelium lower urinary tract symptoms men mouse model multidisciplinary novel therapeutic intervention novel therapeutics prostatitis response urinary urologic

项目摘要

DESCRIPTION (provided by applicant): Lower urinary tract symptoms associated with benign prostatic hyperplasia and prostatitis have a profound impact on quality of life. Urinary tract voiding syndromes that occur in concert with benign prostate disorders are particularly bothersome and, in extreme cases, can be life threatening. The overarching goal of the work proposed here is to define the role of inflammation in benign prostate pathologies, focusing on long-term effects on epithelial cell gene expression, epigenetics, and differentiation. The rationale for undertaking this study is that we hypothesize that the enduring effects of inflammatory events on prostate growth and differentiation are mediated by epigenetic changes in the epithelium, and the epigenome is currently an accessible drug target. Thus, confirmation of this hypothesis by successful completion of the work proposed here would be rapidly translated into patient benefits by informing new therapeutic applications of existing drugs. Evidence from clinical studies strongly implicates aberrant expression of cytokines in etiology of benign prostatic disease. Cytokines are well known to be primary mediators of the inflammatory response but can also have direct effects on epithelial and stromal cells. To determine the consequences of increased proinflammatory cytokine expression in the prostate, a conditional transgenic mouse model will be developed and characterized. The effects of up-regulated ILI 7 and ILI p on prostate inflammation, morphology, gene expression, and epigenetic marks will be analyzed. The extent of pelvic pain coincident with prostate inflammation in the mouse model will also be ascertained. In parallel, human patient material from open prostatectomy and radical prostatectomy cases with inflammation will be characterized. Patterns of gene expression and DNA methylation in reactive and normal epithelia will be quantified in samples from patients with and without lower urinary tract symptoms. These analyses will provide new insights into the effects of inflammation on the transcriptome and eipgenome of human prostate epithelial cells, which can be capitalized upon both diagnostically and therapeutically in future studies to alleviate the morbidity associated with benign prostatic disease and its coincident voiding syndromes.

描述（由申请人提供）：与良性前列腺增生和前列腺炎有关的较低尿路症状对生活质量产生了深远的影响。与良性前列腺疾病共同发生的尿路排尿综合征尤其令人困扰，在极端情况下，可能会威胁生命。这里提出的工作的总体目标是定义炎症在良性前列腺病理中的作用，重点是对上皮细胞基因表达，表观遗传学和分化的长期影响。进行这项研究的理由是，我们假设炎症事件对前列腺生长和分化的持久影响是由上皮的表观遗传变化介导的，而表观基因组目前是可访问的药物靶标。因此，通过成功完成此处提议的工作来确认这一假设，将通过告知现有药物的新治疗应用来迅速转化为患者福利。来自临床研究的证据强烈暗示细胞因子在良性前列腺疾病的病因中的异常表达。众所周知，细胞因子是炎症反应的主要介体，但也可以直接影响上皮细胞和基质细胞。为了确定前列腺中促炎性细胞因子表达增加的后果，将开发和表征有条件的转基因小鼠模型。上调ILI 7和ILI P对前列腺炎症，形态，基因表达和表观遗传标记的影响。还将确定骨盆疼痛与小鼠模型中的前列腺炎症一致的程度。同时，将表征来自开放式前列腺切除术和炎症的根治性前列腺切除术病例的人类患者材料。反应性和正常上皮中的基因表达和DNA甲基化模式将在有和没有尿路症状较低的患者的样品中进行量化。这些分析将为炎症对人前列腺上皮细胞的转录组和EIPGENOME的影响提供新的见解，这些细胞可以在未来的研究中对诊断和治疗中的利用，以减轻与良性前列腺疾病及其一致依次的依从性综合症相关的发病率。